Category Archives: Clinical Cardiology

Care New England Medical Groups pulmonary care division has expanded its clinical services with the addition of three physicians, all members of the Brigham and Womens Pulmonary Associates at Care New England. Their primary hospital affiliation is Kent Hospital and the physicians will see patients in their East Greenwich office Continue reading →

OBJECTIVES: To determine the frequency of obstructive sleep apnea (OSA), insomnia, restless legs, and other sleep symptoms in patients with cardiovascular disease and the association of these sleep disorders with quantitative cardiovascular measures. Study design was a cross-sectional survey and retrospective chart review Continue reading →

The US Food and Drug Administration (FDA) is expected to have data next year that could lead to approval of a renal denervation device to lower blood pressurebut will the data be strong enough to sway skeptics? Medscape interviewed three cardiologists to help answer this and other questions about this procedure, which is investigational in the United States but has the CE mark in Europe Continue reading →

The Architectural Scale Model of the World's First Cleveland Clinic Connected project-Shanghai Luye Lilan Hospital Presented SHANGHAI, Sept. 20, 2019 /PRNewswire/ - Luye Medical and Cleveland Clinic today jointly presented an architectural scale model of the world's first Cleveland Clinic Connected project-the Shanghai Luye Lilan Hospital Continue reading →

PHILADELPHIA, PADapagliflozin added to optimal medical therapy results in meaningful improvements in symptoms and health-related quality of life in heart failure patients with reduced ejection fraction (HFrEF), results of the DEFINE-HF trial show. However, the sodium glucose co-transporter-2 (SGLT2) inhibitor did not reduce levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) compared with placebo. The DEFINE-HF trial, presented here today at the Heart Failure Society of America annual meeting and simultaneously published in Circulation, follows closely on the heels of DAPA-HF, which was presented 2 weeks ago at the European Society of Cardiology Congress 2019 Continue reading →

Compared with white and Hispanic individuals, black men and women have about a 10% higher lifetime risk of developing PAD, according to a new risk-prediction tool created by combining data from some of the largest community-based cohorts in the United States. Between birth and age 80, around three in 10 black individuals have an ankle-brachial index (ABI) below 0.90, researchers found. Continue reading →

When we think of a heart attack, the symptoms that come to mind are pain in the chest and numbness in the left arm. Continue reading →

Welcome to the Department of Cardiovascular Medicine at the University of Kansas Medical Center. Over the past decade, our Department has experienced phenomenal growth in both the clinical and research enterprise - and consistent with this growth, the Department of Cardiovascular Medicine at the University of Kansas Hospital has been ranked in the top 50 programs in the nation for 12 consecutive years by the U.S. News & World Report's annual survey. Continue reading →

COURSE DESCRIPTIONThe purpose of the meeting is to present practical state-of-the-art knowledge in cardiovascular diagnosis and therapy. The scope of the program is comprehensive and will cover prevention, ischemic heart disease, heart failure, valvular heart disease, and heart rhythm disorders. Expert faculty will present evidence-based and practical clinical approaches to diagnosis and treatment. Continue reading →

The standard of practice for out-of-hospital defibrillation is the implantable cardioverter-defibrillator. However, much has been written and discussed about the use of automated external defibrillators. Not as much has been written about life vest wearable defibrillators. Continue reading →